Healthpeak Properties (NYSE:DOC) Reaches New 12-Month High on Analyst Upgrade

Shares of Healthpeak Properties, Inc. (NYSE:DOC) hit a new 52-week high on Monday after Mizuho raised their price target on the stock from $21.00 to $24.00. Mizuho currently has an outperform rating on the stock. Healthpeak Properties traded as high as $21.98 and last traded at $21.8950, with a volume of 7317404 shares trading hands. The stock had previously closed at $21.89.

Other analysts have also issued reports about the stock. Royal Bank Of Canada increased their price target on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Thursday, May 14th. JPMorgan Chase & Co. lifted their price objective on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Citigroup boosted their price objective on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Raymond James Financial began coverage on shares of Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating for the company. Finally, Wells Fargo & Company lifted their price target on shares of Healthpeak Properties from $18.00 to $20.00 and gave the stock an “equal weight” rating in a report on Monday, June 1st. Four investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $20.19.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.23% of the company’s stock.

Institutional Trading of Healthpeak Properties

Several large investors have recently bought and sold shares of DOC. New York Life Investment Management LLC raised its stake in Healthpeak Properties by 65.8% in the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock worth $2,510,000 after acquiring an additional 61,952 shares during the last quarter. Russell Investments Group Ltd. grew its stake in Healthpeak Properties by 176.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust’s stock valued at $58,663,000 after purchasing an additional 1,955,273 shares during the last quarter. Northside Capital Management LLC increased its holdings in shares of Healthpeak Properties by 47.7% in the fourth quarter. Northside Capital Management LLC now owns 472,337 shares of the real estate investment trust’s stock valued at $7,595,000 after purchasing an additional 152,579 shares during the period. Baillie Gifford & Co. increased its holdings in shares of Healthpeak Properties by 613.2% in the fourth quarter. Baillie Gifford & Co. now owns 367,256 shares of the real estate investment trust’s stock valued at $5,905,000 after purchasing an additional 315,763 shares during the period. Finally, Oak Thistle LLC purchased a new position in shares of Healthpeak Properties in the fourth quarter worth about $3,938,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $15.12 billion, a PE ratio of 68.60, a PEG ratio of 3.41 and a beta of 1.02. The firm has a 50 day moving average price of $19.54 and a 200-day moving average price of $17.85.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same quarter in the prior year, the firm earned $0.46 earnings per share. Healthpeak Properties’s revenue for the quarter was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.